MED — Igeamed SpA Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Igeamed SpA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 0.167 | 0.169 | 0.11 | 0.082 | -0.022 |
| Depreciation | |||||
| Non-Cash Items | 0.102 | 0.08 | 0.866 | 0.946 | -0.056 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.515 | -0.009 | -0.956 | -0.298 | 0.031 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.23 | 0.259 | 0.147 | 0.947 | 0.216 |
| Capital Expenditures | -0.037 | -0.173 | -0.527 | -0.787 | -0.06 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | — | — | -0.002 | 0 |
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.037 | -0.173 | -0.527 | -0.789 | -0.06 |
| Financing Cash Flow Items | — | -0.167 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.037 | -0.14 | 0.436 | -0.08 | -0.018 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.23 | -0.054 | 0.056 | 0.078 | 0.137 |